Autophagy regulation as a promising approach for improving cancer immunotherapy

被引:29
|
作者
Ishimwe, Nestor [1 ,2 ,3 ]
Zhang, Wenbin [2 ,3 ]
Qian, Jieying [2 ,3 ]
Zhang, Yunjiao [2 ,3 ,4 ,5 ,6 ]
Wen, Longping [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China
[2] South China Univ Technol, Guangzhou Peoples Hosp 1, Sch Med, Guangzhou 510006, Guangdong, Peoples R China
[3] South China Univ Technol, Inst Life Sci, Guangzhou 510006, Guangdong, Peoples R China
[4] Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China
[5] Key Lab Biomed Engn Guangdong Prov, Guangzhou 510006, Guangdong, Peoples R China
[6] Innovat Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Autophagy modulation; Immunogenic cell death; Cytotoxic T lymphocyte; Immune response; Tumor microenvironment; IMMUNOGENIC CELL-DEATH; T-CELLS; CALRETICULIN EXPOSURE; CROSS-PRESENTATION; SUPPRESSOR-CELLS; IMMUNE-RESPONSES; METABOLISM; SURVIVAL; STAT3; HYDROXYCHLOROQUINE;
D O I
10.1016/j.canlet.2020.01.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Autophagy plays a critical role in intracellular metabolism and maintaining cellular homeostasis. Certain tumor cells present a higher basal autophagy rate and autophagy inhibition can lead to impaired metabolic dysfunction in autophagy-dependent tumor cells. Autophagy status in immune cells dictates their fate and response to antigen; however, autophagy in immune cells may be beneficial or detrimental depending on the developmental stage of the cell and more specifically its degree of differentiation. Autophagy-deficient hosts present variations in many metabolites, proteins and enzymes that may have tumor-promoting or -inhibiting effects. The centrality of autophagy in the metabolism of some cancers and immune cells poses as a critical target whose mechanisms must be further unraveled to optimize patient response and prevent tumor recurrence.
引用
收藏
页码:34 / 42
页数:9
相关论文
共 50 条
  • [31] Immunotherapy for Ovarian Cancer: Disappointing or Promising?
    Deng, Mengqi
    Tang, Fan
    Chang, Xiangyu
    Liu, Penglin
    Ji, Xuechao
    Hao, Menglin
    Wang, Yixiao
    Yang, Ruiye
    Ma, Qingqing
    Zhang, Yubo
    Miao, Jinwei
    MOLECULAR PHARMACEUTICS, 2024, 21 (02) : 454 - 466
  • [32] Ferroptosis: a promising target for cancer immunotherapy
    Sun, Lin-Lin
    Linghu, Dong-Li
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (12): : 5856 - 5863
  • [33] 'Sterile' inflammation and autophagy in cancer immunotherapy
    Harada, Mamoru
    Harashima, Nanae
    IMMUNOTHERAPY, 2010, 2 (05) : 599 - 601
  • [34] Improving the efficacy of cancer immunotherapy
    Copier, J.
    Dalgleish, A. G.
    Britten, C. M.
    Finke, L. H.
    Gaudernack, G.
    Gnjatic, S.
    Kallen, K.
    Kiessling, R.
    Schuessler-Lenz, M.
    Singh, H.
    Talmadge, J.
    Zwierzina, H.
    Hakansson, L.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (08) : 1424 - 1431
  • [35] A promising future in cancer immunotherapy: Oncolytic viruses
    Seyed-Khorrami, Seyed-Mahmood
    Azadi, Arezou
    Rastegarvand, Nasrin
    Habibian, Ala
    Soleimanjahi, Hoorieh
    Los, Marek J.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 960
  • [37] Is Superantigen a Promising Immunotherapy Treatment Against Cancer?
    Al Zahrani, S.
    El Hadad, S.
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (07): : 36 - 42
  • [38] Natural killer cells: a promising immunotherapy for cancer
    Junfeng Chu
    Fengcai Gao
    Meimei Yan
    Shuang Zhao
    Zheng Yan
    Bian Shi
    Yanyan Liu
    Journal of Translational Medicine, 20
  • [39] Cancer Immunotherapy: A promising platform for predicting toxicity
    Ochoa de Olza, Maria
    ELIFE, 2021, 10
  • [40] Bacterial therapy:a promising strategy for cancer immunotherapy
    Yinsong Wang
    Cancer Biology & Medicine, 2023, 20 (11) : 795 - 798